INTELLIPHARMACEUTICS INTERNA (IPCI.CA) Stock Analyst Ratings

Canada • Toronto Stock Exchange • TSX:IPCI • CA4581733090

0.08 CAD
-0.01 (-11.11%)
Last: Mar 5, 2024, 07:00 PM
Buy % Consensus

42

ChartMill assigns a Buy % Consensus number of 42% to IPCI.CA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • IPCI.CA was analyzed by 9 analysts. The buy percentage consensus is at 42. So analysts seem to be rather negative about IPCI.CA.
  • In the previous month the buy percentage consensus was at a similar level.
  • IPCI.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

IPCI.CA Historical Analyst RatingsIPCI.CA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -35 -32 -29 -26 -23 -20 -17 -14 -11 -8 -5 -2 2 4 6 8
IPCI.CA Current Analyst RatingIPCI.CA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades

INTELLIPHARMACEUTICS INTERNA / IPCI.CA FAQ

Can you provide the consensus rating for INTELLIPHARMACEUTICS INTERNA stock?

The consensus rating for INTELLIPHARMACEUTICS INTERNA (IPCI.CA) is 42.2222 / 100 . This indicates that analysts generally have a neutral outlook on the stock.